Member Info for DSFLAT

FG is a grifter

So they offer a performance enhancement on GPU mining equipment that was obsolete when ASICs arrived on the scene years ago

The recent RNS was about porting and with this latest RNS FG would have to teleport back in time for it to be of any value

He got those June placing shares shifted tho

'GPU' ?

So not ASIC ?

My guess is that FG was instructed to put out some fluffy Method B 'new' so the 71M placing shares at 1.4p issued in June could get sold

I could be wrong but sp where it is and large sells going through above 1.4p could support my theory.

FG is prone to hype without substance and the X post and website vids without RNS stick of manipulation of investors imo

Https://coinmarketcap.com/currencies/bitcoin-sv/

BitcoinSV someone knows something ...

My guess is that FG was instructed to put out some fluffy Method B 'new' so the 71M placing shares could get sold

I could be wrong of course ;-)

Catchy name for a revolutionary product 'Method B' ;-)

I hope you guys all do well here but a short video made on 5er .com and more disclaimers than Virgin Galactic don't inspire confidence..

But who knows, some companies prefer to get news out rather than via RNS even if it maybe breaks some rules.

Like I said good luck and I hope you do well

Investors might find this interesting:

Could the BlackRock ETF be a Bitcoin Index?

Joshua Henslee

62 views 18 Oct 2023

https://youtu.be/s0LE58lsSzk?si=GYZbjfPcN9e7G5yZ

Links to the three addresses that accumulated large wallets all starting the same day are in the video notes

Zuckerberg, Dorsey, Saylor & the #BTC Cabal (COPA) represent everything that Bitcoin doesn't

They want to control the money and everyone which is why they are taking satoshi to court 15th Jan

Craig Wright & BSV is fighting the Cabal to benefit everyone

BitcoinSV is Bitcoin and seeing gains as we approach the UK court cases

First is CSW Satoshi, new evidence would suggest he is, then if he wins he will be going for Bitcoin Database rights and BTC passing off as Bitcoin with other cases

DYOR etc It could a be big shift

James Robert Kight hasn't disclosed any purchase or sale of his holding since April 2022 which could be read several ways.

If he's still positive on Evgen he could be waiting to provide funding in any future raise if required which could be seen as positive for shareholders.

If he's not positive on Evgens prospects or happy with last Decembers options grab by BOD who refrain from investing any of their own funds why hasn't he sold any of his 33.1M shares?

Too risky for the SEC to approve any #Bitcoin (#BTC) spot ETF's until COPA v Craig Wright UK court cases which start 15th Jan.

COPA (Zuckerberg, Dorsey, Saylor and BTC Cabal) lose in court and Judge Mellor declares Wright to be Satoshi and things could get ugly for BTC

#BSV 🍿

X (twitter was on fire yesterday when @satoshi account was reinstated...

Bitcoin SV pumped on nchain drama and Calvin Ayre demanding Craig Wright sing satoshi wallets...

https://coinmarketcap.com/currencies/bitcoin-sv/

People are more aware of the COPA (Zuckerberg, Dorsey, Saylor, Gemini BTC devs and just about everyone connected with BTC vs Craig Wright UK court cases due to start 15th Jan 2024.

Satoshi was trending yesterday on X when 4m views flocked to 'satoshi handle...

Certainly gave BSV some much needed attention, if any of the exchanges relist BSV it could be interesting because it's not easy to buy BSV in the USA after it was dropped by Coinbase, Robinhood, Binance, Gemini etc

Interesting times ahead for Bitcoin SV for sure...

I was tempted to post that Brick Top clip from Snatch... Sod it I'll post it

Brick Top - Throw a dog a bone - Snatch - Clip

https://youtu.be/2E1t74HAgpM?si=WuOG0of9fWd2GNc8

Munson just announced a new board appointment who is was a member of Congress and who was hired as an outside lobbyist for Google in 2023 and the sp hardly moved lol

I thought that was a good sign but clearly the market doesn't see it that way ?!?

Quiet on here today ?

Ralf, nothing wrong with that suggestion imo.

However anyone invested in OBD for several years may have sat on paper losses continually averaging down which appears to be the case for it's largest holder of shares...

OBD is an interesting case study (well recent events) August saw a placing and primary bid which presumably allowed ii's to average down as well as pi's..

I agree with you that the BOD not buying even at these low levels isn't a great signal and Hugh suggesting they have been advised they cannot doesn't seem right.

For me there's a lot of potential here but that has to materialise.

Ralf, are you looking at the right Stalicla ? ;-)

DEPI Technology

STALICLA’s precision medicine approach begins with ‘endophenotyping’—identifying the nonbehavioral physical and molecular presentations of NDDs and characterizing subgroups of patients with similar disease signatures.

DEPI matches these patient subgroups with an NDD-targeted drug (or drug combination) by integrating and analyzing large omics data sets, including genomics, proteomics, pharmacogenomics and clinical data.

Once a drug or drug combination is identified as a potential candidate, STALICLA validates its approach through clinical and laboratory studies using patient cells.

http://stalicla.com/approach

Stalicla spent six years researching before coming to Evgen and raised $72M getting their Ducks in a row.

The recent Novartis deal includes undisclosed up-front fees, equity and up to $270M in development and commercial milestones, with additional royalties on sales.

http://stalicla.com/news/press

The Evgen Cancer results are perhaps even more exciting given the much higher death rates over the past three years (since the injectables were rolled out as safe and effective) and the arrival of 'Turbo Cancer'

CJ39 a month ago...

'Kev, you really should listen to KingAlf, Radar and I. We are like your guardian angels, the good guys on your shoulder trying to tell you don’t lose your money. The people who are positive about EVG are like the devil, the bad guy on your shoulder telling you to do it and take the risk and lose your money.'

You seem to have a rather high regard for yourself and the advice of the troll trio lol

OBD was an overnight success five years in the making (I don't follow it but share holders there have been decimated since 2018 by the looks of it)

If you only lost a couple of grand in Evgen why bother posting ?

Ralf might just be looking for a cheaper buy in or he might also be one of those lost a few quid and can't stand the thought of being wrong...

It's not difficult to see that things haven't been great for investors here over the years, but there will be a bottom and good news will shake off these stinky trolls who feel the need to warn people after the event lol

Guys why not sell up and sod off rather than feel the need to troll here..

It's a bit childish TBH

The global (it's not a Globe;) autism spectrum disorder therapeutics market is projected to grow from $2.01 billion in 2023 to $3.42 billion by 2030, at a CAGR of 7.9%...

Read More at:- https://www.fortunebusinessinsights.com/industry-reports/autism-spectrum-disorder-therapeutics-market-101207

very interesting report imo

Total milestones of $160.5m are payable to the Company in relation to the first neurodevelopmental disorder indication under the license. Royalties payable to Evgen on sales are in the low to medium double-digit range in all scenarios, including on-licensing by Stalicla and use of SFX-01 in further licensed indications

STALICLA on Swiss RTS TV

On last Monday September 18th 2023, RTS aired an interview with Lynn Durham, Stalicla’s CEO and Founder, explaining in lay man’s terms our mission and vision as a company: to trail the path towards precision medicine to one day serve every patient in the autism community who feels impaired by his/her symptoms.

http://stalicla.com/news/press/stalicla-RTS-TV

The Stalicla deal was RNS'd a year ago and I'd say Stalicla’s CEO and Founder looks very confident in this recent interview.

The other exciting discoveries in possible Cancers treatments by Evgens medical grade sulphorafane in the past 12 months have perhaps even bigger upside for Evgens SP, patience is key here imo